
Hāʻawi kēia alakaʻi holoʻokoʻa i kahi kikoʻī kikoʻī o ka pathology renal cell carcinoma (RCC), e kālele ana i nā mea pili i nā mea maʻi a me nā limahana lapaʻau ma Kina. E ʻimi mākou i nā ʻano koʻikoʻi, nā ʻano diagnostics, a me nā noʻonoʻo lapaʻau e pili ana me RCC, e kōkua ana iā ʻoe e hoʻomaopopo maikaʻi i kēia maʻi paʻakikī. ʻO ka ʻike i hāʻawi ʻia ma ʻaneʻi no nā kumu hoʻonaʻauao a ʻaʻole pono e manaʻo ʻia he ʻōlelo aʻoaʻo olakino. E kamaʻilio mau me kahi ʻoihana mālama ola no ka ʻike a me ka mālama ʻana.
ʻO RCC cell clear (ccRCC) ka ʻano maʻamau o ʻO ka maʻi maʻi kino o Kina, e helu ana ma kahi o 70-80% o nā hihia āpau. Hōʻike ʻia ʻo ia e ka cytoplasm maʻemaʻe i loko o nā ʻōpū ma muli o ka nui o ka glycogen a me ka lipid content. ʻO ka hoʻomaopopo ʻana i nā hiʻohiʻona histological o ccRCC he mea koʻikoʻi no ka hōʻoia pololei a me ka wānana. ʻO ka noiʻi hou aʻe i ka hoʻololi ʻana o nā genetic kikoʻī e alakaʻi ana i ka ccRCC i loko o ka heluna Kina he wahi o ka noiʻi mau.
ʻO Papillary RCC kekahi ʻano subtype koʻikoʻi o RCC, i hōʻike ʻia e nā ʻano ulu ulu papillary. Hoʻopili pinepine ʻia me kahi wānana ʻoi aku ka maikaʻi ma mua o ka cell RCC maʻemaʻe, akā hiki ke hoʻololi ʻia kēia ma muli o nā kumu like ʻole, me ka pae tumor a me ka pae. Pono ka loiloi pathological o papillary RCC e nānā pono i kāna mau hiʻohiʻona hale a me ka atipia nuklea.
ʻO Chromophobe RCC kahi ʻano maʻamau, e hōʻike pinepine ana i ka cytoplasm eosinophilic a me nā hiʻohiʻona nuklea ʻokoʻa. He ʻokoʻa kona pathogenesis mai ka ccRCC a me ka papillary RCC, a pono e noiʻi hou e hoʻomaopopo i kona prevalence a me nā ʻano ʻokoʻa i loko o ka heluna Kina. Pono paha nā ʻenehana diagnostic kūikawā no ka ʻike pololei.
He kuleana koʻikoʻi ka kiʻi i ka ʻike ʻana a me ka hoʻonohonoho ʻana o ʻO ka maʻi maʻi kino o Kina. Hoʻohana mau ʻia nā ʻenehana e like me CT scans, MRI, a me ultrasound e nānā i ka ʻōpū, nānā i kona nui a me kona wahi, a loiloi i ka nui o ka hoʻouka kaua kūloko a me ka metastasis. Pono ka wehewehe ʻana i kēia mau kiʻi i ka ʻike a me ka noʻonoʻo pono ʻana i nā ʻano maʻi pākahi.
Pono ka biopsy kikoo no ka hōʻoia ʻana. ʻO ka nānā ʻana i ka histopathological o ka laʻana biopsy e hiki ai i nā pathologists ke hoʻokaʻawale i ke ʻano o ka RCC, e loiloi i ka pae tumo (e hōʻike ana i ka ikaika o ka maʻi kanesa), a e ʻike i nā hiʻohiʻona pathological koʻikoʻi, e hāʻawi ana i ka ʻike waiwai no ka hoʻolālā ʻana. ʻO ka pololei o kēia kaʻina hana e hilinaʻi nui ʻia i ka ʻike o nā pathologists loea i ka maʻi maʻi genitourinary.
ʻOkoʻa nā ala lapaʻau no RCC ma muli o ka pae o ka maʻi kanesa, ke olakino holoʻokoʻa o ka mea maʻi, a me nā mea ʻē aʻe. ʻO ka wehe ʻana i ke koko (partial nephrectomy a i ʻole radical nephrectomy) kahi ala maʻamau no ka RCC kūloko. No ka maʻi holomua a metastatic paha, hiki ke noʻonoʻo ʻia nā lāʻau lapaʻau i manaʻo ʻia, immunotherapy, a me ka chemotherapy. ʻO ka loaʻa ʻana i kēia mau koho lapaʻau holomua a me kā lākou pono i loko o ka ʻōnaehana mālama ola Kina he mea nui e noʻonoʻo ai.
No ka ʻike kikoʻī hou aku ma ʻO China renal cell carcinoma pathology outlines a me nā kumuwaiwai pili, makemake paha ʻoe e ʻimi i nā ʻikepili lapaʻau kaulana e like me PubMed. Eia kekahi, he mau keʻena olakino koʻikoʻi ma Kina, e like me ka Shandong Baofa Cancer Research Institute, hāʻawi i ka ʻike a me nā kumuwaiwai ma kēia kahua. E kūkākūkā mau me nā kauka lapaʻau kūpono no ka maʻi a me ka mālama ʻana.
He mea koʻikoʻi ka hoʻomaopopo ʻana i ka pathology o RCC no ka maʻi maʻi, ka mālama ʻana, a me ka prognosis. Hāʻawi kēia alakaʻi i ka ʻike kumu o ʻO ka maʻi maʻi kino o Kina pathology, e hōʻike ana i nā mea nui e pili ana i nā maʻi a me nā mea mālama ola. Ke hoʻomau nei ka noiʻi hou e pili ana i nā ʻano kikoʻī a me nā ala lapaʻau no RCC i loko o ka heluna Kina a e hoʻomaikaʻi i ko mākou ʻike a me ka mālama ʻana i kēia maʻi.